For advertising info, call (813) 951-4200 or or Email us at tony@OurtownFLA.com» more

Regional Medical Center Bayonet Point Continues Its Community Lecture Series on What Everyone Needs to Know About Atrial Fibrillation and Stroke at the Groves Golf and Country Club, 7924 Melogold Circle, Land O’Lakes, FLA

Regional Medical Center Bayonet Point will continue its community lecture series entitled Watchman: What Everyone Needs to Know about Atrial Fibrillation & Stroke on June 29, 2016, at the Groves Golf and Country Club, 7924 Melogold Circle, Land O’Lakes, Florida 34637. The presentation will be conducted by Rami Akel, MD, who will discuss the new procedure to reduce the risk of stroke from atrial fibrillation, leading to the elimination of blood thinners (anti-coagulation medication).

Registration begins at 5 pm and a complimentary dinner will be served at 5:30 pm. Admission is free. Seating is limited and reservations are required. For more information and to register call 727-869-5498 or 888-741-5119.

About Regional Medical Center Bayonet Point

Regional Medical Center Bayonet has been serving the community since 1981. We are a 290-bed acute care hospital located in Hudson, FL and home of the nationally acclaimed Heart Institute. We have more than 350 physicians, 1,264 employees and 500 volunteers on our integrated healthcare delivery team.

Regional Medical Center Bayonet Point has achieved distinction in the following areas:

  • Level II Trauma Center
  • Accredited Chest Pain Center with PCI by the Society of Cardiovascular Patient Care
  • 2010, 2011, 2013 and 2014 Top Performing Hospital for Key Quality Measures for heart attack, heart failure, pneumonia, and surgical care - The Joint Commission
  • Certified Advance Primary Stroke Center - Joint Commission
  • 2014 and 2015 Top Performing Hospital for Key Quality Measures for heart attack, heart failure, pneumonia, surgical care, VTE and stroke - The Joint Commission
  • Heart & Stroke Champions Award Winner 1998 – 2011
  • MRI, CT, Ultrasound, and Nuclear Medicine Accredited - American College of Radiology
  • Approved Community Cancer Program - American College of Surgeons
  • 5 Joint Commission Disease-Specific Certifications: primary stroke center, acute myocardial infarction, coronary artery bypass graft, joint replacement hip, joint replacement knee
  • Awarded Hospital Safety Score of “A” in SIX consecutive rankings by The Leapfrog Group
  • Recipient of the 2014 American Heart Association (AHA)/American Stroke Association’s Get With The Guidelines® Gold Performance Achievement Award in stroke
  • Awarded full Atrial Fibrillation Certification status from the Society of Cardiovascular Patient Care (SCPC)
  • Recipient of 2016 Blue Distinction® Center+ Designation for Quality and Cost-Efficiency in Cardiac Care

Regional Medical Center Bayonet Point is located at 14000 Fivay Road, Hudson, FL. 34667. For additional information on Regional Medical Center Bayonet Point visit www.rmchealth.com or www.heartoftampa.com or visit us on Facebook.

About WATCHMANâ„¢

For patients with atrial fibrillation who are considered suitable for warfarin by their physicians but have reason to seek a non-drug alternative, the Watchman LAAC Implant is an implant alternative to reduce their risk of AF-related stroke. The WATCHMAN Implant closes off an area of the heart called the left atrial appendage (LAA) to keep harmful blood clots from the LAA from entering the blood stream and potentially causing a stroke. By closing off the LAA, the risk of stroke may be reduced and, over time, patients may be able to stop taking warfarin.

People with atrial fibrillation have a five times greater risk of stroke. Atrial fibrillation can cause blood to pool and form clots in the LAA. For patients with non-valvular AF, the LAA is believed to be the source of the majority of stroke-causing blood clots. If a clot forms in the LAA, it can increase one’s risk of having a stroke. Blood clots can break loose and travel in the blood stream to the brain, lungs, and other parts of the body.

WATCHMANâ„¢ Left Atrial Appendage Closure Device from Boston Scientific

The WATCHMAN Device is a permanent implant designed to close the left atrial appendage in the heart in an effort to reduce the risk of stroke. With all medical procedures there are risks associated with the implant procedure and the use of the device. The risks include but are not limited to accidental heart puncture, air embolism, allergic reaction, anemia, anesthesia risks, arrhythmias, AV (Arteriovenous) fistula, bleeding or throat pain from the TEE (Trans Esophageal Echo) probe, blood clot or air bubbles in the lungs or other organs, bruising at the catheter insertion site, clot formation on the WATCHMANâ„¢ Closure Device, cranial bleed, excessive bleeding, gastrointestinal bleeding, groin puncture bleed, hypotension, infection/pneumonia, pneumothorax, pulmonary edema, pulmonary vein obstruction, renal failure, stroke, thrombosis and transient ischemic attack. In rare cases death can occur. Be sure to talk with your doctor so that you thoroughly understand all of the risks and benefits associated with the implantation of the WATCHMAN Device.

Add your comment
Guildelines: Please keep your comments smart and civil. Stay on topic, don't attack other readers personally, and keep your language decent.
blog comments powered by Disqus
ADVERTISEMENT
ADVERTISEMENT
OurTownFLA Facebook OurTownFLA Twitter OurTownFLA Youtube